Interleukin-17 potentially links prolactin to positive symptoms in first-episode drug-naive schizophrenia: An exploratory cross-sectional study.
The immune-inflammation hypothesis of schizophrenia has gained considerable support, yet the role of endocrine-immune interplay remains unclear. Prolactin, a stress-responsive hormone with immunomodulatory properties, is elevated in first-episode drug-naive (FEDN) schizophrenia independently of antipsychotic exposure....